Figures & data
Figure 1. CC: colorectal cancer; IBD: inflammatory bowel disease.
Table 1. Baseline characteristics of case and control cohorts at index (unless otherwise stated) stratified by ostomy type and underlying disease.
Figure 2. Predicted mean healthcare cost, earned income, and income transfer payments per patient-year (€) of case and control cohorts in year 1 and year 2 stratified by ostomy type and underlying disease. Below the figure: For each year, the cases are represented by the first bar and the controls by the second. IBD: inflammatory bowel disease; CC: colorectal cancer; Y: year. Differences between ostomy and matched control cohorts were significant (p < 0.05) except for colostomy: unemployment benefit (p=0.513) in year 2; ileostomy: unemployment benefit (p=0.057) and early retirement pension (p=0.714) in year 1 and age pension (p=0.072) in year 2; ileostomy with IBD: unemployment benefit (p=0.482) in year 1, and early retirement pension (p=0.543) and age pension (0.880) in year 2; ileostomy with CC: unemployment benefit (p=0.418), early retirement pension (p=0.431)), and age pension (p=0.053) in year 2. Please refer to Table S5 for exact values and confidence intervals.
Table 2. Predicted mean inpatient costs per patient-year (€) of common ostomy-related complications in case and control cohorts in year 1 and year 2 stratified by ostomy type and underlying disease.
Table 3. Predicted mean costs per patient-year (€) of general practitioner and selected prescription medication according to indication in case and control cohorts in year 1 and year 2 stratified by ostomy type and underlying disease.